Agilon Health, Inc. Form 8-K Summary
Business Context and Reporting Period
Agilon Health, Inc. filed a Form 8-K reporting the final results of its annual meeting of stockholders held on May 29, 2024. The filing was submitted under Item 5.07, “Submission of Matters to a Vote of Security Holders.”
Financial and Operating Metrics
The filing does not provide financial statements, revenue, profit, cash flow, margin, debt, liquidity, or operating guidance information.
Annual Meeting Results
- Election of directors: Ravi Sachdev, Steven J. Sell, and William Wulf, M.D. were elected as Class III directors to serve until the 2027 annual meeting and until their successors are elected and qualified.
- Director vote totals: Sachdev received 359,574,466 votes for, 25,246,100 against, 106,890 abstentions, and 7,698,907 broker non-votes. Sell received 362,777,063 for, 22,042,462 against, 107,931 abstentions, and 7,698,907 broker non-votes. Wulf received 359,928,894 for, 24,926,633 against, 71,929 abstentions, and 7,698,907 broker non-votes.
- Independent auditor: Stockholders ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, with 391,453,808 votes for, 1,087,702 against, and 84,853 abstentions.
- Executive compensation: Stockholders approved, on a non-binding advisory basis, the compensation paid to the named executive officers. The vote was 318,678,236 for, 66,152,444 against, 96,776 abstentions, and 7,698,907 broker non-votes.
Material Changes, Outlook, and Risks
The filing reports no material changes to financial condition, business outlook, guidance, contingencies, or risk factors. Its substantive content is limited to annual meeting voting results.
Important Facts to Verify
- Confirm the elected directors’ Class III terms and board committee assignments in subsequent company disclosures.
- Verify Ernst & Young LLP’s appointment for the fiscal year ending December 31, 2024.
- Review the company’s subsequent quarterly and annual filings for financial performance, liquidity, debt, guidance, and any matters not addressed in this 8-K.